Publicaciones en las que colabora con T. Castillo Triviño (16)

2022

  1. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

    Frontiers in Immunology, Vol. 13

2021

  1. Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models

    ACS Chemical Neuroscience, Vol. 12, Núm. 5, pp. 893-905

  2. O group is a protective factor for COVID19 in Basque population

    PLoS ONE, Vol. 16, Núm. 4 April

  3. Profiling of plasma extracellular vesicle transcriptome reveals that circrnas are prevalent and differ between multiple sclerosis patients and healthy controls

    Biomedicines, Vol. 9, Núm. 12

2020

  1. RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers

    Human Molecular Genetics, Vol. 29, Núm. 20, pp. 3361-3372

  2. Whole-transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal igm band characterization reveals two circular RNAs and two linear rnas as biomarkers of highly active disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-16

2018

  1. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

2017

  1. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis

    Human Molecular Genetics, Vol. 26, Núm. 18, pp. 3564-3572

2016

  1. SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent

    Scientific Reports, Vol. 6

2015

  1. Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis

    BMC Genomics, Vol. 16, Núm. 1

2014

  1. Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

    Multiple Sclerosis Journal, Vol. 20, Núm. 14, pp. 1851-1859

  2. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis

    Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661

  3. Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa

    Revista de Neurologia, Vol. 58, Núm. 8, pp. 337-344

  4. Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. HLA-DRB1*15:01 and multiple sclerosis: A female association?

    Multiple Sclerosis Journal, Vol. 18, Núm. 5, pp. 569-577

2009

  1. Differential micro RNA expression in PBMC from multiple sclerosis patients

    PLoS ONE, Vol. 4, Núm. 7